‘Directly acting’ on the uptake of DOACs with RWD

Written by Darcy Hodge, Editor

Prescription prices

A study conducted by researchers from the Yale School of Medicine (CT, USA), published in JAMA Network Open, has suggested that uptake of oral anticoagulants in clinical practice is lacking, despite previous research has suggested that oral anticoagulants may be safer than the status quo, warfarin. The research implies this may be due to variations in prescription prices under Medicare. Data on the administration of direct-acting oral anticoagulants (DOACs) was assessed by the team using real-world data (RWD). The RWD included Medicare Provider Utilization and Payment data, collected between 2013 and 2018. In total, the claims of 325,666 prescribers who...

To view this content, please register now for access

It's completely free